Lioujia, Taiwan

Wei-Hsuan Chen




Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • LiouJia Township, TW (2011)
  • Lioujia Township, Tainan County, TW (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Adverse Drug Reaction Detection by Wei-Hsuan Chen

Introduction

Wei-Hsuan Chen, an accomplished inventor based in Lioujia, Taiwan, has made significant contributions to the field of pharmacogenetics. With two patents to his name, he focuses on the detection of specific HLA alleles that are associated with adverse drug reactions. His work aims to enhance patient safety and improve treatment outcomes.

Latest Patents

Wei-Hsuan Chen's latest patents revolve around the development of methods for detecting HLA alleles linked to adverse drug reactions. His inventions include a system for determining the presence of critical genetic markers, such as HLA-B*1502 and HLA-B*5801. These methods enable healthcare professionals to assess the risk of patients developing serious conditions like Stevens-Johnson syndrome, toxic epidermal necrolysis, or hypersensitivity syndrome based on the presence or absence of these genetic markers. Additionally, Chen has designed a kit that facilitates the detection of these alleles, further advancing personalized medicine.

Career Highlights

Wei-Hsuan Chen has held significant roles at renowned institutions, including Academia Sinica and Pharmigene, Inc. Throughout his career, he has contributed to groundbreaking research and development projects aimed at improving drug safety through genetic testing. His dedication to innovation has positioned him as a notable figure in the medical and scientific communities.

Collaborations

During his professional journey, Wei-Hsuan Chen has collaborated with esteemed colleagues such as Yuan-Tsong Chen and Shuen-Iu Hung. These partnerships have led to shared knowledge and advancements in the study of genetics and its applications to pharmacology.

Conclusion

Wei-Hsuan Chen's innovative work in the detection of HLA alleles associated with adverse drug reactions exemplifies the crucial intersection of genetics and patient care. His patents not only contribute to the scientific understanding of drug reactions but also pave the way for personalized treatment approaches. As advancements in this field continue, Chen’s contributions will remain essential to improving patient safety and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…